30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Apimeds Pharmaceuticals US Inc (APUS)

Stock chart
Ticker: APUS Exchange: ASE


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Kim Christopher
Chairman and CMO
1 purchase — total 14,378 USD
Buy 14 May 2025
Value US$4,914,604.72 | Price 224.18 | Shares 90,388
Buy 13 May 2025
Value US$3,104,080.01 | Price 219.15 | Shares 88,194
Buy 12 May 2025
Value US$56,715.00 | Price 1.99 | Shares 28,500
Buy 12 May 2025
Value US$2,000,000.00 | Price 4.00 | Shares 500,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2025-05-15 2025-05-14 B Purchase

Chairman and CMO

Executive Director
90,388 +44.1%
224.18
US$4,914,605
90,388 +44.1% 224.18 US$4,914,605
2025-05-15 2025-05-13 B Purchase

Chairman and CMO

Executive Director
88,194 -20.8%
219.15
US$3,104,080
88,194 -20.8% 219.15 US$3,104,080
2025-05-14 2025-05-12 B Purchase Non-Executive Director
44,972 +49.9%
306.81
US$1,821,767
44,972 +49.9% 306.81 US$1,821,767
2025-05-14 2025-05-12 B Purchase Large shareholder
500,000 +33.7%
4.00
US$2,000,000
500,000 +33.7% 4.00 US$2,000,000